Search results
Piper Sandler raises Myriad Genetics target to $28, keeps Overweight By Investing.com
Investing.com· 37 minutes agoOn Monday, Piper Sandler adjusted its outlook on Myriad Genetics (NASDAQ:MYGN), increasing the...
Taking a Closer Look At Myriad Genetics, Inc.
Knox Daily· 31 minutes agoIn a filing, Myriad Genetics, Inc. revealed its Chief Financial Officer Riggsbee Richard Bryan unloaded Company’s shares for reported $0.57 million on Dec ...
Myriad Genetics (NASDAQ:MYGN) shareholders have endured a 26% loss from investing in the stock five...
Simply Wall St. via Yahoo Finance· 6 days agoIdeally, your overall portfolio should beat the market average. But in any portfolio, there will be...
Earnings call: Myriad Genetics posts strong Q1 with revenue growth By Investing.com
Investing.com· 5 days agoMyriad Genetics (NASDAQ:MYGN), a leading player in genetic testing and precision medicine, has...
Analysts Have Made A Financial Statement On Myriad Genetics, Inc.'s (NASDAQ:MYGN) First-Quarter...
Simply Wall St. via Yahoo Finance· 2 days agoAs you might know, Myriad Genetics, Inc. (NASDAQ:MYGN) just kicked off its latest first-quarter...
Myriad Genetics (NASDAQ:MYGN) Hits New 52-Week High at $24.92
ETF DAILY NEWS· 3 days agoMyriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Thursday . The company traded as high ...
Myriad Genetics (MYGN) Posts Narrower-Than-Estimate Loss in Q1
Zacks via Yahoo Finance· 5 days agoMyriad Genetics (MYGN) first-quarter average revenue per test across its product portfolio benefited...
Myriad Genetics Reports Q1 2024 Earnings: Revenue Growth Surpasses Estimates Amidst Challenges
GuruFocus.com via Yahoo Finance· 6 days agoOperational Developments: Announced the reorganization of European operations and the sale of the...
Myriad Genetics Inc (MYGN) Q1 2024 Earnings Call Transcript Highlights: Strong Start with ...
GuruFocus.com via Yahoo Finance· 5 days agoExplore key insights from Myriad Genetics' Q1 2024 earnings, featuring significant revenue increases and strategic initiatives aimed at enhancing market position.
Myriad Genetics First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 4 days agoMyriad Genetics (NASDAQ:MYGN) First Quarter 2024 Results Key Financial Results Revenue: US$202.2m...
